COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,083 Articles (22,658 medRxiv, 8,425 bioRxiv)

Most recent first Previous |  Page 2407: Articles 24061-24070  | Next

Does sampling saliva increase detection of SARS-CoV-2 by RT-PCR? Comparing saliva with oro-nasopharyngeal swabs
Akgun Dogan, O., Kose, B., Agaoglu, N. B., Yildiz, J., Alkurt, G., Kendir Demirkol, Y., Irvem, A., Dinler-Doganay, G., Doganay, L.
10.1101/2020.07.26.20158618 — Posted: 2020-07-28
A Bayesian Framework for Estimating the Risk Ratio of Hospitalization for People with Comorbidity Infected by the SARS-CoV-2 Virus
Gao, X., Dong, Q.
10.1101/2020.07.25.20162131 — Posted: 2020-07-28 Discussion: Onsite
Public Reactions towards the COVID-19 Pandemic on Twitter in the United Kingdom and the United States
Zou, C., Wang, X., Xie, Z., Li, D.
10.1101/2020.07.25.20162024 — Posted: 2020-07-28
Capping Mobility to Control COVID-19: A Collision-based Infectious Disease Transmission Model
Shi, Y., Ban, X.
10.1101/2020.07.25.20162016 — Posted: 2020-07-28
Massive-scale biological activity-based modeling identifies novel antiviral leads against SARS-CoV-2
Huang, R., Xu, M., Zhu, H., Chen, C. Z., Lee, E., He, S., Shamim, K., Bougie, D., Huang, W., Hall, M., Lo, D., Simeonov, A., Austin, C., Qiu, X., Tang, H., Zheng, W.
10.1101/2020.07.27.223578 — Posted: 2020-07-27
Predicting the Emergence of SARS-CoV-2 Clades
Jain, S., Xiao, X., Bogdan, P., Bruck, J.
10.1101/2020.07.26.222117 — Posted: 2020-07-27
Evolution And Genetic Diversity Of SARSCoV-2 In Africa Using Whole Genome Sequences
Motayo, B. O., Oluwasemowo, O. O., Akinduti, P. A., Olusola, B. A., Arege, O. T., Faneye, A. O.
10.1101/2020.07.27.222901 — Posted: 2020-07-27
An alternative binding mode of IGHV3-53 antibodies to the SARS-CoV-2 receptor binding domain
Wu, N. C., Yuan, M., Liu, H., Lee, C.-C. D., Zhu, X., Bangaru, S., Torres, J. L., Caniels, T. G., Brouwer, P. J. M., van Gils, M. J., Sanders, R. W., Ward, A. B., Wilson, I. A.
10.1101/2020.07.26.222232 — Posted: 2020-07-27 Discussion: Onsite
An antibody-dependent enhancement (ADE) activity eliminated neutralizing antibody with potent prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys
Gui, X.
10.1101/2020.07.26.222257 — Posted: 2020-07-27
Structure and inhibition of the SARS-CoV-2 main protease reveals strategy for developing dual inhibitors against Mpro and cathepsin L
Sacco, M. D., Ma, C., Lagarias, P., Gao, A., Townsend, J. A., Meng, X., Dube, P., Zhang, X., Hu, Y., Kitamura, N., Hurst, B., Tarbet, B., Marty, M. T., Kolocouris, A., Xiang, Y., Chen, Y., Wang, J.
10.1101/2020.07.27.223727 — Posted: 2020-07-27 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).